We are monitoring the impact of COVID-19 on Europe Sepsis Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 2825
Share on
Share on

Europe Sepsis Diagnostics Market Research Report – Segmented By Pathogen, Product , Technology, Method , Usability, & By Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2020 to 2025)

Pulished: February, 2020
ID: 2825
Pages: 145

Europe Sepsis Diagnostics Market Size (2020 to 2025)

The size of the Sepsis Diagnostics Market in Europe is valued at USD 397.15 Million in 2020, growing at a CAGR of 8.43%, to reach USD 595.26 Million by 2025 during the forecast period.

Sepsis Diagnosis is the rise as the incidence rate, and prevalence of sepsis is on the rise. Sepsis is a severe illness condition occurring when the body reacts to a foreign body infection, be it bacterial, viral, fungal, or parasitic. It is one of the most death-causing diseases in hospitals. The contamination leads to organ dysfunction or failure and systemic inflammation. Its symptoms are hypertension, high body temperature, shivering, and elevated heart rate. The increasing prevalence of the disease and its fatal effects have stimulated its growth.

Factors like high incidence rates of hospital-acquired infections, rising prevalence of different antibiotic-resistant bacterial strains, increasing geriatric population, a growing number of surgical procedures, and an increasing number of product approvals driving the market forward.

Yet, factors like lack of standard protocols, lack of awareness, and shortage, or skilled staff are likely to obstruct the growth of the market.

This research report segmented and sub-segmented the market into the following categories:

  • By Pathogen: Bacterial and Fungal
  • By Product: Instruments, Blood Culture Media, Assay Kits, and Reagents.
  • By Technology: Molecular Diagnostics, Microbiology, Immunoassay and Flow Cytometry
  • By Method: Conventional and Automated
  • By Usability: Laboratory and POC
  • By Country: United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

Promising companies operating in the market profiled in this report are bioMérieux SA, T2 Biosystem Inc, Cepheid, Thermo Fisher Scientific Inc., Nanosphere Inc, Abbott Laboratories, Roche Diagnostics Limited, Becton, Dickinson and Company, Bruker Corporation, and Beckman Coulter, Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Pathogen                    

                                5.1.1 Introduction           

                                5.1.2 Bacterial Sepsis     

                                                5.1.2.1 Gram-Negative Bacterial Sepsis

                                                5.1.2.2 Gram-Positive Bacterial Sepsis

                                5.1.3 Fungal Sepsis         

                                5.1.4 Other Pathogen Infections              

                                5.1.5  Y-o-Y Growth Analysis, By Pathogen           

                                5.1.6  Market Attractiveness Analysis, By Pathogen         

                                5.1.7  Market Share Analysis, By Pathogen          

                5.2 Product                        

                                5.2.1 Introduction           

                                5.2.2 Instruments           

                                5.2.3 Blood Culture Media           

                                5.2.4 Assay Kits & Reagents        

                                5.2.5 Software  

                                5.2.6 Y-o-Y Growth Analysis, By Product               

                                5.2.7 Market Attractiveness Analysis, By Product             

                                5.2.8 Market Share Analysis, By Product               

                5.3 Technology                 

                                5.3.1 Introduction           

                                5.3.2 Microbiology          

                                5.3.3 Molecular Diagnostics        

                                5.3.4 Immunoassays      

                                5.3.5 Flow Cytometry    

                                5.3.6 Other Technologies             

                                5.3.7 Y-o-Y Growth Analysis, By Technology        

                                5.3.8  Market Attractiveness Analysis, By Technology     

                                5.3.9  Market Share Analysis, By Technology       

                5.4 Method                       

                                5.4.1 Introduction           

                                5.4.2 Convential Diagnostics       

                                5.4.3 Automated Diagnostics     

                                5.4.4 Y-o-Y Growth Analysis, By Method               

                                5.4.5  Market Attractiveness Analysis, By Method            

                                5.4.6  Market Share Analysis, By Method             

                5.5 Usability                       

                                5.5.1 Introduction           

                                5.5.2 Laboratory Testing               

                                5.5.3 Point-of-Care Testing         

                                5.5.4 Y-o-Y Growth Analysis, By Usability              

                                5.5.5 Market Attractiveness Analysis, By Usability            

                                5.5.6 Market Share Analysis, By Usability              

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Pathogen

                                                6.1.3.3 By Product

                                                6.1.3.4 By Technology

                                                6.1.3.5 By Method

                                                6.1.3.6 By Usability

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Pathogen

                                                6.1.4.3 By Product

                                                6.1.4.4 By Technology

                                                6.1.4.5 By Method

                                                6.1.4.6 By Usability

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Pathogen

                                                6.1.5.3 By Product

                                                6.1.5.4 By Technology

                                                6.1.5.5 By Method

                                                6.1.5.6 By Usability

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 bioMérieux SA                          

                                8.1.1 Overview 

                                8.1.2 Pathogen Analysis               

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 T2 Biosystem Inc                      

                8.3 Cepheid                       

                8.4 Thermo Fisher Scientific Inc.                               

                8.5 Nanosphere Inc                        

                8.6 Abbott Laboratories                               

                8.7 Roche Diagnostics Limited                    

                8.8 Becton, Dickinson and Company                       

                8.9 Bruker Corporation                 

                8.10 Beckman Coulter, Inc                           

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Europe Sepsis Diagnostics Market By Pathogen, From 2020 to 2025 (USD Billion)
  2. Europe Bacterial Sepsis Diagnostics Market By Region, From 2020 to 2025 (USD Billion)
  3. Europe Fungal Sepsis Diagnostics Market By Region, From 2020 to 2025 (USD Billion)
  4. Europe Other Pathogen Infections Market By Region, From 2020 to 2025 (USD Billion)
  5. Europe Sepsis Diagnostics Market By Products, From 2020 to 2025 (USD Billion)
  6. Europe Instruments Market By Region, From 2020 to 2025 (USD Billion)
  7. Europe Blood Culture Media Market By Region, From 2020 to 2025 (USD Billion)
  8. Europe Assay Kits and Reagents Market By Region, From 2020 to 2025 (USD Billion)
  9. Europe Software Market By Region, From 2020 to 2025 (USD Billion)
  10. Europe Sepsis Diagnostics Market By Technology, From 2020 to 2025 (USD Billion)
  11. Europe Molecular Diagnostics Market By Region, From 2020 to 2025 (USD Billion)
  12. Europe Microbiology Market By Region, From 2020 to 2025 (USD Billion)
  13. Europe Immunoassay Market By Region, From 2020 to 2025 (USD Billion)
  14. Europe Flow Cytometry Market By Region, From 2020 to 2025 (USD Billion)
  15. Europe Sepsis Diagnostics Market By Method, From 2020 to 2025 (USD Billion)
  16. Europe Conventional Sepsis Diagnostics Market By Region, From 2020 to 2025 (USD Billion)
  17. Europe Automated Sepsis Diagnostics Market By Region, From 2020 to 2025 (USD Billion)
  18. Europe Sepsis Diagnostics Market By Usability, From 2020 to 2025 (USD Billion)
  19. Europe Laboratory Testing Market By Region, From 2020 to 2025 (USD Billion)
  20. Europe Point-of-Care Testing Market By Region, From 2020 to 2025 (USD Billion)
  21. U.K. Sepsis Diagnostics Market By Pathogen, From 2020 to 2025 (USD Billion)
  22. U.K. Sepsis Diagnostics Market By Products, From 2020 to 2025 (USD Billion)
  23. U.K. Sepsis Diagnostics Market By Technology, From 2020 to 2025 (USD Billion)
  24. U.K. Sepsis Diagnostics Market By Method, From 2020 to 2025 (USD Billion)
  25. U.K. Sepsis Diagnostics Market By Usability, From 2020 to 2025 (USD Billion)
  26. Germany Sepsis Diagnostics Market By Pathogen, From 2020 to 2025 (USD Billion)
  27. Germany Sepsis Diagnostics Market By Products, From 2020 to 2025 (USD Billion)
  28. Germany Sepsis Diagnostics Market By Technology, From 2020 to 2025 (USD Billion)
  29. Germany Sepsis Diagnostics Market By Method, From 2020 to 2025 (USD Billion)
  30. Germany Sepsis Diagnostics Market By Usability, From 2020 to 2025 (USD Billion)
  31. France Sepsis Diagnostics Market By Pathogen, From 2020 to 2025 (USD Billion)
  32. France Sepsis Diagnostics Market By Products, From 2020 to 2025 (USD Billion)
  33. France Sepsis Diagnostics Market By Technology, From 2020 to 2025 (USD Billion)
  34. France Sepsis Diagnostics Market By Method, From 2020 to 2025 (USD Billion)
  35. France Sepsis Diagnostics Market By Usability, From 2020 to 2025 (USD Billion)
  36. Italy Sepsis Diagnostics Market By Pathogen, From 2020 to 2025 (USD Billion)
  37. Italy Sepsis Diagnostics Market By Products, From 2020 to 2025 (USD Billion)
  38. Italy Sepsis Diagnostics Market By Technology, From 2020 to 2025 (USD Billion)
  39. Italy Sepsis Diagnostics Market By Method, From 2020 to 2025 (USD Billion)
  40. Italy Sepsis Diagnostics Market By Usability, From 2020 to 2025 (USD Billion)
  41. Spain Sepsis Diagnostics Market By Pathogen, From 2020 to 2025 (USD Billion)
  42. Spain Sepsis Diagnostics Market By Products, From 2020 to 2025 (USD Billion)
  43. Spain Sepsis Diagnostics Market By Technology, From 2020 to 2025 (USD Billion)
  44. Spain Sepsis Diagnostics Market By Method, From 2020 to 2025 (USD Billion)
  45. Spain Sepsis Diagnostics Market By Usability, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample